Lisa Diller

Preferential amplification of the paternal allele of the N–myc gene in human neuroblastomas

Anna Naumova, C. Sapienza, L. Diller, 1993, Nature Genetics.

Purged versus non-purged peripheral blood stem-cell transplantation for high-risk neuroblastoma (COG A3973): a randomised phase 3 trial.

John M Maris, Richard Sposto, J. Maris, 2013, The Lancet. Oncology.

Hyperdiploidy plus nonamplified MYCN confers a favorable prognosis in children 12 to 18 months old with disseminated neuroblastoma: a Pediatric Oncology Group study.

John M Maris, Rani E George, A. Look, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Caring for cancer survivors

Julie S Najita, Eric G Campbell, Elyse R Park, 2009, Cancer.

Activating mutations in ALK provide a therapeutic target in neuroblastoma

D. Gary Gilliland, Stefan Fröhling, Wendy B. London, 2008, Nature.